6 reports

Patients were randomized in a ##:## fashion to active drug versus placebo.

  • Allergy
  • Allergy Immunotherapy
  • Therapy
  • Company
  • Aimmune Therapeutics, Inc.

THE DRUG CANDIDATE ACTS BY TARGETING DIPEPTIDASE-##.

  • Blood Disease
  • Pathology
  • Pharmaceutical
  • Therapy
  • Company

THE DRUG CANDIDATE IS A ## MER PEPTIDE ACTS BY TARGETING PROGRAMMED CELL DEATH ## LIGAND ## (PD-L##).

  • Blood Disease
  • Pharmaceutical
  • Therapy
  • Company
  • Bristol-Myers Squibb Company

Two out of the six were considered possibly related to study drug: one in Group ## and one in Group ##.

  • Antifungal
  • Infectious Disease
  • Pharmaceutical
  • Therapy
  • Company

THE DRUG CANDIDATE IS IN PHASE II STAGE FOR PEANUT ALLERGY IN ADULTS AND PEDIATRICS, GRASS POLLEN ALLERGY AND DERMATITIS GLOBALLY.

  • Pathology
  • Pharmaceutical
  • Respiratory Disease
  • Therapy
  • Company

(allergy and autoimmune diagnostics) which was sold to Thermo Fisher Scientific (TMO) in September of 2011.

  • Gene Therapy
  • Ophthalmology
  • Pharmaceutical
  • Therapy
  • Company